RECHERCHE :   Cancers digestifs
Filtrage ? Le champ de filtrage permet de trier les études comportant le mot saisie. La recherche du mot se fait uniquement dans le contenu texte affiché à l'écran.
ETUDE PHASE SITE
AMGEN 20120139: A Registry Study to Evaluate the Survival and Long-Term Safety of Subjects Who Previously Received Talimogene Laherparepvec in Amgen or BioVEX-Sponsored Clinical Trials
Tous les types de tumeurs
registre
CHUV
AMGEN 20140318 - T-VEC intrahepatic: A Phase 1b/2, Multicenter, Open-label Trial to Evaluate the Safety of Talimogene Laherparepvec Injected into Liver Tumors Alone and in Combination With Systemic Pembrolizumab
Tumeur du foie non opérable (HCC) ou non-HCC
I, II
CHUV, HUG
BP40234: An Open-Label, Multicenter, Phase II Study to Evaluate the Therapeutic Activity of RO6874281, an Immunocytokine, Consisting of Interleukin-2 Variant (IL-2v) Targeting Fibroblast Activation Protein-Α (FAP), in Combination With Atezolizumab (Anti-PD-L1), Administered Intravenously, in Participants With Advanced and/or Metastatic Solid Tumors
Tumeurs solides (ORL, œsophage, col de l'utérus)
II
CHUV, HUG
DANTE: A randomized, open-label Phase II efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in patients with gastric cancer and adenocarcinoma of the oesophago-gastric junction.
Gastric cancer and adenocarcinoma of the oesophago-gastric junction
II
HUG
DCC-2618-03-002 Intrigue: A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib
Advanced Gastrointestinal Stromal tumor
III
CHUV
EORTC 1560 ILOC study: Phase II of immunotherapy plus local tumor ablation (RFA or stereotactic radiotherapy) in patients with colorectal cancer liver metastases:
Colorectal cancer liver metastasis
II
HUG
INNOVATION: INtegratioN of trastuzumab, with or without pertuzumab, into periOperatiVe chemotherApy of HER-2 posiTIve stOmach caNcer
Cancer de l'estomac HER-2 positif
II
CHUV, HUG
MK3475-937: A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) versus Placebo as Adjuvant Therapy in Participants with Hepatocellular Carcinoma and Complete Radiological Response after Surgical Resection or Local Ablation
Hepatocellular carcinoma after surgical resection
III
CHUV, HUG
CO39612_MORPHEUS CRC: A phase Ib/II, open-label, multicenter, randomized umbrella study evaluating the efficacy and safety of multiple immunotherapy-based treatment combinations in patients with metastatic colorectal cancer.
Cancer coloréctal métastatique
I, II
CHUV
PEMREC:A Phase II Study to Evaluate Safety and Efficacy of Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer
Localised MSS Rectal Cancer
II
HUG
PRODIGE 32: Systematic surgery vs. monitoring and salvage surgery in operable oesophageal cancer in complete clinical response after chemoradiation. Strategic multicenter randomised phase II-III trial
Cancer de l'oesophage
II, III
HUG
RACIN, A phase I study of the combination of nivolumab associated with low-dose radiation, aspirin/ celecoxib and either ipilimumab or low-dose cyclophosphamide, followed by nivolumab maintenance, in patients with advanced, TIL-negative solid tumors
Tumeurs solides
I
CHUV
SAKK 41/13: Adjuvant aspirin treatment in PIK3CA mutated colon cancer patients. A randomized, double-blinded, placebo-controlled, phase III trial.
Cancer du côlon PIK3CA muté
III
CHUV, HUG
SAKK 41/14: Physical activity program in patients with metastatic colorectal cancer who receive palliative first-line chemotherapy. A multicenter open label randomized controlled phase III trial
Activité physique chez des patients recevant une chimiothérapie pour un cancer colorectal
III
HUG
CHUV-DO-0012-SolTIL-2018 - Phase Ib Study To Assess The Feasibility And Safety Of Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes In Advanced Solid Tumors
Tumeurs solides
I
CHUV
AMGEN 20140299 - T-VEC Colorectal: A Phase 1b Study of Talimogene Laherparepvec in Combination With Atezolizumab in Subjects With Colorectal Cancer With Liver Metastases
Cancer colorectal avec métastases hépatiques
I
HUG